Confidently Navigating ADPKD: Understanding the New KDIGO Guideline, ADPKD in Women & Children: Special Considerations

ADPKD presents unique challenges for women, pregnant individuals, and children. In our final session (Part 4 of 4), we’ll focus on pregnancy risks, hypertension, birth control considerations, and pediatric care strategies. This session will include plenty of time for questions, so you can get expert insights tailored to your concerns. Learning Objectives:

• Understand pregnancy risks, preeclampsia, and hypertension in ADPKD.
• Learn about birth control options & how hormones influence cyst growth.
• Explore screening & management strategies for pediatric ADPKD.
• Gain insights into genetic counseling & family planning for ADPKD families.

Speakers:

• Dr. Arlene Chapman, M.D., is a renowned nephrologist specializing in hereditary and rare renal diseases, including ADPKD. A leading researcher in cyst formation mechanisms and precision medicine, she has received continuous NIH funding for nearly two decades and has published extensively.
• Dr. Chapman also plays a vital role in academic leadership, mentorship, and translational medicine at the University of Chicago.
• Dr. Ashima Gulati, M.D., Ph.D., is a pediatric nephrologist specializing in inherited kidney diseases, with a focus on polycystic kidney disease. Trained at Yale School of Medicine, her research integrates human exome analysis and disease modeling in mice and zebrafish to study genetic kidney diseases and vascular complications in autosomal dominant polycystic kidney disease.
• Dr. Dallas Reed, M.D., is the Chief of Genetics and an Assistant Professor at Tufts University School of Medicine, specializing in obstetrics and gynecology as well as medical genetics. She has particular expertise in preconception and prenatal genetic counseling, genetic syndromes, and cancer risk assessment.